François Ducray

12PUBLICATIONS
180CO-AUTHORS
Predictive and prognostic markersCentral nervous systemMolecular targetsNanomedicineCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Florien W Boele, Sé M Frances, Amélie Darlix

|Dec 03, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle

|Aug 19, 2024
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.

Dario De Alcubierre, Grigorios Gkasdaris, Margaux Mordrel

|Jun 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

Martin J van den Bent, Pim J French, Daniel Brat

|Jun 10, 2024
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.

Ines Esparragosa Vazquez, Marc Sanson, Olivier L Chinot

|Apr 29, 2022
Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases.

Thiébaud Picart, Chloé Dumot, Jacques Guyotat

Pageof 2

Frequent Collaborators

5 joint publications

David Meyronet

5 joint publications

Thiébaud Picart

3 joint publications

Johan Pallud

3 joint publications

Marc Barritault